CN112999156A - 一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法 - Google Patents

一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法 Download PDF

Info

Publication number
CN112999156A
CN112999156A CN202110235848.2A CN202110235848A CN112999156A CN 112999156 A CN112999156 A CN 112999156A CN 202110235848 A CN202110235848 A CN 202110235848A CN 112999156 A CN112999156 A CN 112999156A
Authority
CN
China
Prior art keywords
nano
coated
oil
liposome
essential oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110235848.2A
Other languages
English (en)
Other versions
CN112999156B (zh
Inventor
陆伟
李�杰
郑宇强
晏永球
郁新弟
于善凯
王鹏泽
马云龙
贾福怀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Yufangtang Biotechnology Co ltd
Original Assignee
Ningbo Yufangtang Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo Yufangtang Biotechnology Co ltd filed Critical Ningbo Yufangtang Biotechnology Co ltd
Priority to CN202110235848.2A priority Critical patent/CN112999156B/zh
Publication of CN112999156A publication Critical patent/CN112999156A/zh
Application granted granted Critical
Publication of CN112999156B publication Critical patent/CN112999156B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268Asarum (wild ginger)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/758Zanthoxylum, e.g. pricklyash
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法,采用碳酸甘油酯/丙二醇/乙醇溶剂体系,获得了透明易喷雾液态物,解决了困扰行业多年的育亨宾高剂量溶解的难题;所得喷剂彻底避开了经典延时神油因使用利多卡因苯佐卡因及达克罗宁等化学合成麻麻醉剂对人体的诸多伤害,科学规避了前列腺素E1等生物制品极速助勃剂对阴茎造成的长时间充血、水肿、隐约刺痛及膨胀幻觉等后遗症,具有助勃、延时、提高性生活质量且无后遗症的效果;育亨宾盐酸盐/纳米包裹精油脂质体/碳酸甘油酯体系与醇水组合物共同制得的喷剂,可通过阴茎局部喷淋透皮技术,疗效快速确切,无任何毒副作用,即便长期使用也不会产生任何不良作用。

Description

一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法
技术领域
本发明涉及一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法。
背景技术
随着时代的进步与现代化节奏的加快,工作与生活压力日益加大,男性面临着愈发激烈的竞争,饱受疾病困扰,尤其是勃起功能障碍。美国麻省一项相关调查显示,该地52%的男性遇到此类性健康问题的困惑,数据惊人。男性性功能障碍,不仅影响男性患者的身体健康,更易导致自信心不足及抑郁等心理问题,严重影响男性生活质量与性伴侣及家庭的和谐幸福。
男性性功能障碍包括:性欲低下甚至无性欲、无力勃起、早泄、无法射精、无高潮体验等。此类病因错综复杂,可包括神经损伤、血管内皮损伤、代谢异常、营养、药物、心理因素和不良生活方式等。
经典的治疗男性勃起功能障碍的药物主要有前列地尔注射剂和栓剂甚至睾丸素注射剂,使用不便且不安全。
目前对性功能障碍的治疗多限于口服中西药及食疗,食疗(包括口服名目繁多的壮阳助性类保健食品)时间长效果不确切;中药口服药量大,需持之以恒,经胃肠酸碱分解,有效成分破坏严重,且全身吸收缓慢,有效成分局部利用少,疗效难以充分发挥。以西地那非为代表的西药虽然效果快,但长期使用依赖性与耐受性强,剂量越用越大,副作用强烈,往往表现为手足振颤、面红耳赤、心率加快、头痛等不良症状,更有甚者,美国已报道了40例因服用伟哥而导致失明的病案,这可能与服用伟哥造成球后静脉栓塞有关。
为克服口服剂及注射剂的不足,业界又推出富含前卫科技成果的经皮给药制剂如前列腺素E1乳膏及前列腺素E1脂质体分散液等,以涂抺及喷雾方法作用于阴茎,目标明确,使用方式新颖而简便、给药安全、起效快速,但久用后阴茎肿胀感明显,制剂的贮藏稳定性始终没有重大突破,限制了此类产品的大规模普及。
发明内容
本发明所要解决的第一个技术问题是针对现有技术的现状,提供一种能助勃、延时、提高性生活质量且无后遗症的盐酸育亨宾增效的助勃延时精油喷剂。
本发明所要解决的第二个技术问题是针对现有技术的现状,提供一种上述盐酸育亨宾增效的助勃延时精油喷剂的制备方法,该方法以纳米包裹天然植物精油为原料,以天然来源的育亨宾盐酸盐为增效剂,借助天然化增溶促渗溶剂体系,从而达到助勃、延时、提高性生活质量且无后遗症的效果。
本发明解决至少一个上述技术问题所采用的技术方案为:一种盐酸育亨宾增效的助勃延时精油喷剂,其特征在于:按重量计,包括以下步骤:
Figure BDA0002960066940000021
上述各组分均选自可用于化妆品的医药级原料,而且组份本身或组份每个基团均源自天然,最终可分解成天然产物。盐酸育亨宾为源自天然的育亨宾盐酸盐,首选医药级白色粉未,含量99%以上的市售产品;碳酸甘油酯为二氧化碳与脱水后的甘油经高温高压工艺,在高效催化剂作用下的反应产物,含量大于93.5%,外观无色、无气味并透明,首选美国亨斯曼公司的医药级或化妆品级产品;丙二醇和乙醇为用于化妆品的食品添加剂,优选无色透明市售高纯产品;丁香油为源自天然的精油,优选用于化妆品的食品级产品;水为纯化水、蒸馏水或去离子水。
在本发明中,所述的纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体为纳米级分散液,由天然细辛精油/天然麻椒精油/天然樟脑精油、食品级抗坏血酸、辛癸酸甘油酯、食用磷脂、胆固醇、食用乙醇、食用甘油和水组成。采用上述纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体组分,可与育亨宾盐酸盐及碳酸甘油酯相互作用,使天然药用助勃成份与精油的速效性正面作用超常发挥,不仅助勃迅捷,延时明显,而且更能使阴茎在射精后保持相当时间的坚挺度。
优选地,按重量计,所述的纳米包裹细辛油脂质体成品由以下组分构成:
Figure BDA0002960066940000022
Figure BDA0002960066940000031
优选地,按重量计,所述的纳米包裹麻椒油脂质体成品由以下组分构成:
Figure BDA0002960066940000032
优选地,按重量计,所述的纳米包裹樟脑油脂质体成品由以下组分构成:
Figure BDA0002960066940000033
上述配方中,由于因包裹而获得长时间稳定的脂质体超细粒径的高效渗透作用,使纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体的延时效果显著
一种上述盐酸育亨宾增效的助勃延时精油喷剂的制备方法,其特征在于包括以下步骤:
(1)纳米包裹精油脂质体产品预调制
按照配比将纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体的各组分混合后通过孔径为200nm-50nm的高压挤出仪连续挤压,得到粒径≤200nm的纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体,备用;
(2)盐酸育亨宾溶解
在配料锅中,搅拌条件下,将99%盐酸育亨宾投入93.5%的碳酸甘油酯液体中,升温至60~75℃,溶解至少0.5小时至体系完全透明;在搅拌条件下,控制转速100rpm,加入99%丙二醇,冷至40℃,加入天然丁香油,搅拌至近透明,加入99%乙醇,搅拌至完全透明;
(3)调合过程
在搅拌条件下,控制转速100rpm,控温40℃,将33%纳米包裹细辛油脂质体、10%纳米包裹麻椒油脂质体和10%纳米包裹樟脑油脂质体10%分别分批投入步骤(2)所得料液中,搅拌,加纯化水,得完全透明产品;陈化后即得到所述的盐酸育亨宾增效的助勃延时精油喷剂。
在上述方案中,所述纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体具体由以下步骤获得:
按照配方称取食用磷脂、胆固醇、天然细辛精油/天然麻椒精油/天然樟脑精油,溶于无水乙醇中,加热至60℃回流反应1h,旋转蒸干;
加入辛癸酸甘油酯和油酸,在70℃下搅拌溶解,得混合液,补充注射入水和甘油,然后于高速组织捣碎机中,以10000转/分搅拌3~5分钟;
通过孔径为200nm-50nm的高压挤出仪连续挤压上述物料,即得到粒径≤200nm的纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体。
与现有技术相比,本发明的优点在于:本发明采用碳酸甘油酯/丙二醇/乙醇溶剂体系,获得了透明易喷雾液态物,解决了困扰行业多年的育亨宾高剂量溶解的难题;所得喷剂彻底避开了经典延时神油因使用利多卡因苯佐卡因及达克罗宁等化学合成麻麻醉剂对人体的诸多伤害,科学规避了前列腺素E1等生物制品极速助勃剂对阴茎造成的长时间充血、水肿、隐约刺痛及膨胀幻觉等后遗症,具有助勃、延时、提高性生活质量且无后遗症的效果;
本发明的育亨宾盐酸盐/纳米包裹精油脂质体/碳酸甘油酯体系与醇水组合物共同制得的喷剂,可通过阴茎局部喷淋透皮技术,利用生殖系统极其丰富的血液循环,使有效成分高效吸收,达到药物的最大化利用,疗效快速确切,无任何毒副作用,即便长期使用也不会产生任何不良作用;
本发明喷剂久用还可提升男性起勃速度,有效改善阳萎,具有显著的调理功能。
具体实施方式
以下结合实施例对本发明作进一步详细描述。
按照重量组分计,本发明实施例1~5的配方如下:
Figure BDA0002960066940000041
Figure BDA0002960066940000051
其中,按重量计,33%纳米包裹细辛油脂质体成品由以下组分构成:
Figure BDA0002960066940000052
按重量计,10%纳米包裹麻椒油脂质体成品由以下组分构成:
Figure BDA0002960066940000053
按重量计,10%纳米包裹樟脑油脂质体成品由以下组分构成:
Figure BDA0002960066940000054
Figure BDA0002960066940000061
在上述各实施例中,盐酸育亨宾增效的助勃延时精油喷剂的制备方法为:
(1)纳米包裹精油脂质体产品预调制
按照以上配方称取食用磷脂、胆固醇、天然细辛精油/天然麻椒精油/天然樟脑精油,溶于无水乙醇中,加热至60℃回流反应1h,旋转蒸干;
加入辛癸酸甘油酯和油酸,在70℃下搅拌溶解,得混合液,补充注射入水和甘油,然后于高速组织捣碎机中,以10000转/分搅拌3~5分钟;
通过孔径为200nm-50nm的高压挤出仪连续挤压上述物料,即得到粒径≤200nm的33%纳米包裹细辛油脂质体/10%纳米包裹麻椒油脂质体/10%纳米包裹樟脑油脂质体,备用;
(2)盐酸育亨宾溶解
在100立升不锈钢配料锅中,搅拌条件下,控制转速100rpm,将99%盐酸育亨宾投入93.5%的碳酸甘油酯液体中,升温至70℃,溶解0.5小时至体系完全透明;在搅拌条件下,控制转速100rpm,加入99%丙二醇,冷至40℃,加入天然丁香油,搅拌至近透明,加入99%乙醇,搅拌至完全透明;
(3)调合过程
在搅拌条件下,控制转速100rpm,控温40℃,将33%纳米包裹细辛油脂质体、10%纳米包裹麻椒油脂质体和10%纳米包裹樟脑油脂质体10%分别分批投入步骤(2)所得料液中,搅拌,加纯化水,得完全透明产品;陈化后即得到盐酸育亨宾增效的助勃延时精油喷剂。
以下通过试验对本发明所得盐酸育亨宾增效的助勃延时精油喷剂的效果进行验证:
Figure BDA0002960066940000062
Figure BDA0002960066940000071
可见,本发明的盐酸育亨宾增效的助勃延时精油喷剂能助勃、延时、提高性生活质量且无后遗症。

Claims (7)

1.一种盐酸育亨宾增效的助勃延时精油喷剂,其特征在于:按重量计,包括以下步骤:
Figure FDA0002960066930000011
2.根据权利要求1所述的盐酸育亨宾增效的助勃延时精油喷剂,其特征在于:所述的纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体为纳米级分散液,由天然细辛精油/天然麻椒精油/天然樟脑精油、食品级抗坏血酸、辛癸酸甘油酯、食用磷脂、胆固醇、食用乙醇、食用甘油和水组成。
3.根据权利要求2所述的盐酸育亨宾增效的助勃延时精油喷剂,其特征在于:按重量计,所述的纳米包裹细辛油脂质体成品由以下组分构成:
Figure FDA0002960066930000012
4.根据权利要求2所述的盐酸育亨宾增效的助勃延时精油喷剂,其特征在于:按重量计,所述的纳米包裹麻椒油脂质体成品由以下组分构成:
Figure FDA0002960066930000013
Figure FDA0002960066930000021
5.根据权利要求2所述的盐酸育亨宾增效的助勃延时精油喷剂,其特征在于:按重量计,所述的纳米包裹樟脑油脂质体成品由以下组分构成:
Figure FDA0002960066930000022
6.一种权利要求2~5中任一权利要求所述盐酸育亨宾增效的助勃延时精油喷剂的制备方法,其特征在于包括以下步骤:
(1)纳米包裹精油脂质体产品预调制
按照配比将纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体的各组分混合后通过孔径为200nm-50nm的高压挤出仪连续挤压,得到粒径≤200nm的纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体,备用;
(2)盐酸育亨宾溶解
在配料锅中,搅拌条件下,将99%盐酸育亨宾投入93.5%的碳酸甘油酯液体中,升温至60~75℃,溶解至少0.5小时至体系完全透明;在搅拌条件下,控制转速100rpm,加入99%丙二醇,冷至40℃,加入天然丁香油,搅拌至近透明,加入99%乙醇,搅拌至完全透明;
(3)调合过程
在搅拌条件下,控制转速100rpm,控温40℃,将33%纳米包裹细辛油脂质体、10%纳米包裹麻椒油脂质体和10%纳米包裹樟脑油脂质体10%分别分批投入步骤(2)所得料液中,搅拌,加纯化水,得完全透明产品;陈化后即得到所述的盐酸育亨宾增效的助勃延时精油喷剂。
7.根据权利要求6所述的制备方法,其特征在于:所述纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体具体由以下步骤获得:
按照配方称取食用磷脂、胆固醇、天然细辛精油/天然麻椒精油/天然樟脑精油,溶于无水乙醇中,加热至60℃回流反应1h,旋转蒸干;
加入辛癸酸甘油酯和油酸,在70℃下搅拌溶解,得混合液,补充注射入水和甘油,然后于高速组织捣碎机中,以10000转/分搅拌3~5分钟;
通过孔径为200nm-50nm的高压挤出仪连续挤压上述物料,即得到粒径≤200nm的纳米包裹细辛油脂质体/纳米包裹麻椒油脂质体/纳米包裹樟脑油脂质体。
CN202110235848.2A 2021-03-03 2021-03-03 一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法 Active CN112999156B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110235848.2A CN112999156B (zh) 2021-03-03 2021-03-03 一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110235848.2A CN112999156B (zh) 2021-03-03 2021-03-03 一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法

Publications (2)

Publication Number Publication Date
CN112999156A true CN112999156A (zh) 2021-06-22
CN112999156B CN112999156B (zh) 2023-09-08

Family

ID=76403955

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110235848.2A Active CN112999156B (zh) 2021-03-03 2021-03-03 一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法

Country Status (1)

Country Link
CN (1) CN112999156B (zh)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587167A (en) * 1993-09-14 1996-12-24 Choi; Hyung K. Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
CN101167879A (zh) * 2007-11-08 2008-04-30 金城 增加勃起硬度、延长性交持久力制剂及含有制剂的安全套
US20090022829A1 (en) * 2007-07-19 2009-01-22 Cheng Jin Lubricant Additive To Enhance Staying Power Of Male Erectile Function
CN101375949A (zh) * 2008-09-27 2009-03-04 曹开镛 一种早泄外用制剂及其制备方法
CN102863439A (zh) * 2011-07-07 2013-01-09 天津市尖峰天然产物研究开发有限公司 从育亨宾树皮中提取育亨宾盐酸盐的方法
US20150216880A1 (en) * 2013-01-21 2015-08-06 Edward M. Lichten Inducing lactation in nursing females
CN106038711A (zh) * 2016-06-29 2016-10-26 王守亮 一种用于防治早泄的中药组合物及其制备方法和制剂
CN110151829A (zh) * 2019-03-14 2019-08-23 东莞古圣堂药业有限公司 一种改善男性性生活时间的外用延时剂
CN110151828A (zh) * 2019-03-14 2019-08-23 东莞古圣堂药业有限公司 一种延长男性同房时间的延时剂
CN112137960A (zh) * 2020-09-28 2020-12-29 广州市香雪制药股份有限公司 精油脂质体及其制备方法和应用

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587167A (en) * 1993-09-14 1996-12-24 Choi; Hyung K. Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
US20090022829A1 (en) * 2007-07-19 2009-01-22 Cheng Jin Lubricant Additive To Enhance Staying Power Of Male Erectile Function
CN101167879A (zh) * 2007-11-08 2008-04-30 金城 增加勃起硬度、延长性交持久力制剂及含有制剂的安全套
CN101375949A (zh) * 2008-09-27 2009-03-04 曹开镛 一种早泄外用制剂及其制备方法
CN102863439A (zh) * 2011-07-07 2013-01-09 天津市尖峰天然产物研究开发有限公司 从育亨宾树皮中提取育亨宾盐酸盐的方法
US20150216880A1 (en) * 2013-01-21 2015-08-06 Edward M. Lichten Inducing lactation in nursing females
CN106038711A (zh) * 2016-06-29 2016-10-26 王守亮 一种用于防治早泄的中药组合物及其制备方法和制剂
CN110151829A (zh) * 2019-03-14 2019-08-23 东莞古圣堂药业有限公司 一种改善男性性生活时间的外用延时剂
CN110151828A (zh) * 2019-03-14 2019-08-23 东莞古圣堂药业有限公司 一种延长男性同房时间的延时剂
CN112137960A (zh) * 2020-09-28 2020-12-29 广州市香雪制药股份有限公司 精油脂质体及其制备方法和应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MORA, OA ET AL.: "Effect of adrenergic blockade on the pheromonal restoration of cyclic activity in young oestrogen-primed persistent oestrous female rats", JOURNAL OF NEUROENDOCRINOLOGY, vol. 14, pages 200 - 206 *
陈颖等: "星点设计-效应面法优化α-细辛脑脂质体喷鼻剂的制备工艺", 《中国药房》 *
陈颖等: "星点设计-效应面法优化α-细辛脑脂质体喷鼻剂的制备工艺", 《中国药房》, vol. 24, 31 December 2013 (2013-12-31), pages 431 - 434 *

Also Published As

Publication number Publication date
CN112999156B (zh) 2023-09-08

Similar Documents

Publication Publication Date Title
KR102093872B1 (ko) 지방제거용 주사제 조성물 및 이의 제조방법
CN100506208C (zh) 蟾酥纳米脂质体及其制备方法
WO2022160970A1 (zh) 一种不含乙醇的难溶性药物浓缩液以及由其制备的胶束溶液
US20220079880A1 (en) Solid micellar compositions of cannabinoid acids
US20120040970A1 (en) Intranasal delivery system for dantrolene
US20220142915A1 (en) Dental Local Anesthetic Solution
CN101756886A (zh) 局部皮肤用咪喹莫特微乳凝胶剂及其制备方法
CN112999156A (zh) 一种盐酸育亨宾增效的助勃延时精油喷剂及其制备方法
JPH0840880A (ja) 軟ゼラチンカプセル剤中のケトプロフエン溶液に基づく医薬製剤およびその調製法
JP7190571B2 (ja) ブレイアコニチンaの用途
CN116370411A (zh) 一种丙酸氟替卡松鼻喷雾剂及其生产工艺
CN103690473B (zh) 一种青藤碱制剂及其制备方法
CN105106118A (zh) 一种总蟾毒内酯纳米立方液晶及其制备方法
CN114642635B (zh) 萜烯类药物组合物的口服乳剂及其制备方法和用途
EP0505374A1 (en) VITAMIN-MINERAL TREATMENT METHODS AND COMPOSITIONS.
CN101491495B (zh) 丹酚酸b镁注射剂、制备方法及应用
CN111110633B (zh) 一种他达拉非喷雾剂及其制备方法
JP2016513686A (ja) フルチカゾンの経皮製剤
CN102406605A (zh) 雄性激素类药物的醇质体制剂及其制备方法
WO2005049053A1 (en) Composition comprising a magnesium compound and/or a magnesium saltfor improving sexual dysfunction
CN110339169A (zh) 包覆维生素d和维生素k的纳米囊泡制剂及其应用
CN111481559B (zh) 一种高浓度的氟维司群组合物及其制备方法
CN112439066A (zh) 包含化学消融剂和pH调节剂的药物组合物及其应用
CN1491647A (zh) 经皮式用于治疗阳痿和女性性冷淡并防治性病的组合物
CN104257607A (zh) 一种紫杉醇注射液及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Lu Wei

Inventor after: Yan Yongqiu

Inventor after: Yu Xindi

Inventor after: Yu Shankai

Inventor after: Wang Pengze

Inventor after: Ma Yunlong

Inventor after: Jia Fuhuai

Inventor before: Lu Wei

Inventor before: Li Jie

Inventor before: Zheng Yuqiang

Inventor before: Yan Yongqiu

Inventor before: Yu Xindi

Inventor before: Yu Shankai

Inventor before: Wang Pengze

Inventor before: Ma Yunlong

Inventor before: Jia Fuhuai

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant